Independent histological risk factors for lymph node metastasis of superficial esophageal squamous cell carcinoma; implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection

Diseases of the Esophagus

Volumn 23, Issue 5, 2010, Pages 398-407

  Chiba, T ^a   Kawachi, H ^a   Kawano, T ^a   Kumagai, J ^a   Kitagaki, K ^a   Sekine, M ^a   Uchida, K ^a   Kobayashi, M ^a   Sugihara, K ^a   Eishi, Y ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Claudin 5; Esophagus; Lymph node metastasis; Squamous cell carcinoma; Submucosal invasion

Indexed keywords

BETA CATENIN; CLAUDIN 1; CLAUDIN 5; CLAUDIN 7; MATRILYSIN; UVOMORULIN; CLDN5 PROTEIN, HUMAN; MEMBRANE PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ENDOSCOPIC SURGERY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SUPERFICIAL CANCER; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT INDICATION; UNIVARIATE ANALYSIS; CARCINOMA, SQUAMOUS CELL; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; SECONDARY; TUMOR INVASION;

CARCINOMA, SQUAMOUS CELL; CLAUDIN-5; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954908749     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.01023.x     Document Type: Article

References (45)

1. Comprehensive registry of esophageal cancer in Japan. http://esophagus.jp, Japan Esophageal Society, 3rd edition. 2002 [Cited May 1, 2009.] Available from URL:
2. Takubo K, Aida J, Sawabe M. Early squamous cell carcinoma of the esophagus: the Japanese viewpoint. Histopathology 2007, 51:733-42.
3. Hamilton S, Aaltonen L. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System 2000, (IARC Press). eds, Lyon
4. Guidelines for clinical and pathologic studies on carcinoma of the esophagus, ninth edition: preface, general principles, part I. Esophagus 2004, 1:61-88. Japanese Society for Esophageal Diseases
5. Guidelines for clinical and pathologic studies on carcinoma of the esophagus, ninth edition: part II. Esophagus 2004, 1:107-26. Japanese Society for Esophageal Diseases
6. Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 2000, 13:125-9.
7. Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer 2002, 94:570-5.
8. Tomita N, Matsumoto T, Hayashi T. Lymphatic invasion according to D2-40 immunostaining is a strong predictor of nodal metastasis in superficial squamous cell carcinoma of the esophagus: algorithm for risk of nodal metastasis based on lymphatic invasion. Pathol Int 2008, 58:282-7.
9. Eguchi T, Nakanishi Y, Shimoda T. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 2006, 19:475-80.
10. Egashira H, Yanagisawa A, Kato Y. Predictive factor for lymph node metastasis in esophageal squamous cell carcinomas contacting or penetrating the muscularis mucosae: the utility of droplet infiltration. Esophagus 2006, 3:47-52.
11. Chibana Y, Fujii S, Ichikawa K. Tumor cell dissociation score highly correlates with lymph node metastasis in superficial esophageal carcinoma. J Gastroenterol Hepatol 2005, 20:1371-8.
12. Natsugoe S, Uchikado Y, Okumura H. Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep 2007, 17:517-23.
13. Zhang G, Zhou X, Xue L. Accumulation of cytoplasmic beta-catenin correlates with reduced expression of E-cadherin, but not with phosphorylated Akt in esophageal squamous cell carcinoma: immunohistochemical study. Pathol Int 2005, 55:310-7.
14. Usami Y, Chiba H, Nakayama F. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol 2006, 37:569-77.
15. Tanioka Y, Yoshida T, Yagawa T. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 2003, 89:2116-21.
16. Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 2000, 6:1169-74.
17. Lioni M, Brafford P, Andl C. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol 2007, 170:709-21.
18. Morita K, Furuse M, Fujimoto K, Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A 1999, 96:511-6.
19. Matter K, Balda M S. Holey barrier: claudins and the regulation of brain endothelial permeability. J Cell Biol 2003, 161:459-60.
20. Neuhaus W, Wirth M, Plattner V E, Gabor F, Noe C R. Expression of Claudin-1, Claudin-3 and Claudin-5 in human blood-brain barrier mimicking cell line ECV304 is inducible by glioma-conditioned media. Neurosci Lett 2008, 446:59-64.
21. Mays T A, Binkley P F, Lesinski A. Claudin-5 levels are reduced in human end-stage cardiomyopathy. J Mol Cell Cardiol 2008, 45:81-7.
22. Nitta T, Hata M, Gotoh S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003, 161:653-60.
23. Takala H, Saarnio J, Wiik H, Soini Y. Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior. APMIS 2007, 115:838-47.
24. Soini Y, Tommola S, Helin H, Martikainen P. Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch 2006, 448:52-8.
25. Miettinen M, Sarlomo-Rikala M, Sobin L H, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 2000, 24:211-22.
26. Franchi A, Gallo O, Massi D, Baroni G, Santucci M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 2004, 101:973-8.
27. Bukholm I K, Nesland J M, Borresen-Dale A L. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [see comments. J Pathol 2000, 190:15-9.
28. Shiozaki H, Tahara H, Oka H. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991, 139:17-23.
29. Ueno H, Yamashita K, Azumano I, Inoue M, Okada Y. Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas. Int J Cancer 1999, 84:470-7.
30. Morita K, Sasaki H, Furuse M, Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999, 147:185-94.
31. Reyes J L, Lamas M, Martin D. The renal segmental distribution of claudins changes with development. Kidney Int 2002, 62:476-87.
32. Xiangming C, Hokita S, Nuruki K. The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer. Surg Today 1998, 28:587-94.
33. Xiangming C, Hokita S, Natsugoe S. Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. Oncology 1999, 57:131-7.
34. Saeki H, Tanaka S, Sugimachi K. Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer. Dig Dis Sci 2002, 47:2738-42.
35. Sung S S, Fu S M, Rose C E, Gaskin F, Ju S T, Beaty S R. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J Immunol 2006, 176:2161-72.
36. Rescigno M, Rotta G, Valzasina B, Ricciardi-Castagnoli P. Dendritic cells shuttle microbes across gut epithelial monolayers. Immunobiology 2001, 204:572-81.
37. Pfeiffer F, Kumar V, Butz S. Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node. Eur J Immunol 2008, 38:2142-55.
38. Zhao X J, Li H, Chen H. Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis. World J Gastroenterol 2003, 9:225-32.
39. Ueno H, Mochizuki H, Hashiguchi Y. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004, 127:385-94.
40. Ueno H, Price A B, Wilkinson K H, Jass J R, Mochizuki H, Talbot I C. A new prognostic staging system for rectal cancer. Ann Surg 2004, 240:832-9.
41. Gotoda T, Sasako M, Ono H, Katai H, Sano T, Shimoda T. Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer. Br J Surg 2001, 88:444-9.
42. Haruta H, Hosoya Y, Sakuma K. Clinicopathological study of lymph-node metastasis in 1,389 patients with early gastric cancer: assessment of indications for endoscopic resection. J Dig Dis 2008, 9:213-8.
43. Kitajima K, Fujimori T, Fujii S. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol 2004, 39:534-43.
44. Kim D U, Lee J H, Min B H. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J Gastroenterol Hepatol 2008, 23:619-25.
45. Tajima Y, Nakanishi Y, Ochiai A. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer 2000, 88:1285-93.